Effect of streptozotocin induced diabetes on rat hippocampus

Bratislava Medical Journal

Volumn 113, Issue 10, 2012, Pages 583-588

  Pamidi, N ^a   Satheesha Nayak, B ^a  

^a MELAKA MANIPAL MEDICAL COLLEGE   (India)

Author keywords

Diabetes; Hippocampus; Neurons; Streptozotocin

Indexed keywords

COLORING AGENT; CRESYL VIOLET; OXAZINE DERIVATIVE; STREPTOZOCIN;

ANIMAL; ARTICLE; EXPERIMENTAL DIABETES MELLITUS; HIPPOCAMPUS; MALE; NERVE CELL; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; COLORING AGENTS; DIABETES MELLITUS, EXPERIMENTAL; HIPPOCAMPUS; MALE; NEURONS; OXAZINES; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84871821600     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2012_130     Document Type: Article

References (22)

1. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia 1994; 37 (7): 643-650.
2. Revsin Y, Saravia F, Roig P, Lima A, de Kloet ER, Homo-Delarche F, De Nicola AF. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res 2005; 1038 (1): 22-31.
3. Miyata S, Saitoh A, Hirano S, Kamei J. Effect of streptozotocininduced diabetes on the function of the central nervous system in rodents. Nihon Shinkei Seishin Yakurigaku Zasshi 2006; 26 (2): 83-87.
4. Wang GX, Li GR, Wang YD, Yang TS, Ouyang YB. Characterization of neuronal cell death in normal and diabetic rats following experimental focal cerebral ischemia. Life Sci 2001; 69 (23): 2801-2810.
5. Zhang WJ, Tan YF, Yue JT, Vranic M, Wojtowicz JM. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol Scand 2008; 117 (3): 205-210.
6. Ryan CM. Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 1988; 11 (1): 86-93.
7. Bliss TV, Collingridge GL. Asynaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361:31-39
8. Saravia F, Revsin Y, Lux-Lantos V, Beauquis J, Homo-Delarche F, De Nicola AF. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. J Neuroendocrinol 2004; 16 (8): 704-710.
9. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008; 11 (3): 309-317.
10. Kamal A, Biessels GJ, Urban IJ, Gispen WH. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 1999; 90 (3): 737-745.
11. Joghataie MT, Roghani M, Jalali MR, Baluchnejadmojarad T, Sharayeli M. Dendritic Spine Changes in Medial Prefrontal Cortex of Male Diabetic Rats Using Golgi-Impregnation Method. Arch Iranian Med 2007; 10 (1): 54-58.
12. Kamal A, Biessels GJ, Duis SEJ, Gispen W H. Learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats:interaction of diabetes and ageing. Diabetologia 2000; 43 (4): 500-506.
13. Jackson-Guilford J, Leander JD, Nisenbaum LK. The effect of streptozotocin induced diabetes on cell proliferation in the rat dentate gyrus. Neurosci Lett 2000; 293 (2): 91-94.
14. Dagon Y, Avraham Y, Link G, Zolotarev O, Mechoulam R, Berry EM. The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic heochromocytoma PC12 cells. Neurobiol Dis 2007; 27 (2): 174-181.
15. Wisniewski K, Fedosiewicz-Wasiluk M, Holy ZZ, Car H, Grzeda E. Influence of NMDA, a potent agonist of glutamate receptors, on behavioral activity in 4-week streptozotocin-induced diabetic rats. Pol J Pharmacol 2003; 55 (3): 345-351.
16. Gallego M, Setien R, Izquierdo MJ, Casis O, Casis E. Diabetesinduced biochemical changes in central and peripheral catecholaminergic systems. Physiol Res 2003; 52 (6): 735-741.
17. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998; 21:127-148.
18. Makimattila S, Malmberg-Ceder K, Hakkinen AM et al. Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 2004; 24 (12): 1393-1399.
19. Kumar TP, Antony S, Gireesh G, George N, Paulose CS. Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats. J Biomed Sci 2010; 17:43.
20. Parihar MS, Chaudhary M, Shetty R, Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 2004; 11 (4): 397-402.
21. Reagan LP, McEwen BS. Diabetes, but not stress, reduces neuronal nitric oxide synthase expression in rat hippocampus: implications for hippocampal synaptic plasticity. Neuroreport 2002; 13 (14): 1801-1804.
22. Nitta A, Murai R, Suzuki N et al. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol 2002; 24 (5): 695-701.